Drivers of revenue growth included more customers using multiple chronic condition programs as well as strong adoption of GLP ...

Cencora is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With over $250 billion in annual US healthcare distribution sales, the company supplies ...

Revenue reached $67.2 billion, beating analyst estimates by 7.3% (non-GAAP) and growing 11% year over year. Adjusted earnings per share (EPS) rose to $7.20, surpassing expectations and EPS increased 7 ...

Novo Nordisk slashed its profit forecast owing to slower sales growth for its Ozempic diabetes and Wegovy weight-loss treatments in the U.S. Its blockbuster GLP-1 drugs have been losing market ...

President Donald Trump sent letters to the leaders of 17 major pharmaceutical companies outlining how they should slash U.S. prescription drug prices to match those paid overseas, the White House ...

President Donald Trump called out 17 Big Pharma CEOs over "exorbitant" drug pricing in individual letters sent out Thursday, the White House said.

CVS Health Corporation (NYSE:CVS) is one of the largest pharmaceutical retailers in America.

Luka Dončić responds to criticism about his body pre-weight loss The Los Angeles Lakers star shared whether his slimmer look is a reaction to comments about his conditioning and appearance last ...

After Mikayla Nogueira unveiled her 60-pound weight loss transformation, the TikToker cleared the air on how she accomplished the feat, saying she did it "naturally." ...

Luka Doncic isn't the only athlete in the City of Angels trimming down. The Los Angeles Rams feature a weapon who opened up about his own weight loss.

Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a profit warning and named a new CEO, as it battles rising competition in ...

Novo Nordisk (NVO) stock plunged on Tuesday, down over 21% at the closing bell after the company behind the viral weight-loss drug Wegovy and diabetes treatment Ozempic slashed its sales and ...